Related Experiment Videos
Introduction to the focussed section on molecular and cellular biology in hypertension
1Alton Oschner Medical Foundation, New Orleans, Louisiana 70121.
Cardiovascular Drugs and Therapy
|November 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Isolated systolic hypertension in elderly WKY is reversed with L-arginine and ACE inhibition.
Hypertension (Dallas, Tex. : 1979)·2001
Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats.
Hypertension (Dallas, Tex. : 1979)·2001
Local hemodynamic changes in hypertension: insights for therapeutic preservation of target organs.
Hypertension (Dallas, Tex. : 1979)·2001
Low-dose ACE with alpha- or beta-adrenergic receptor inhibitors have beneficial SHR cardiovascular effects.
Journal of cardiovascular pharmacology and therapeutics·2001
Fibrosis and ischemia: the real risks in hypertensive heart disease.
American journal of hypertension·2001
Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR: interaction with angiotensin type 2 receptors.
Hypertension (Dallas, Tex. : 1979)·2001
Liraglutide Ameliorates Atrial Fibrillation in Association with Enhanced Adiponectin Signaling in Epicardial Adipose Tissue.
Cardiovascular drugs and therapy·2026
Energetic Decoding of VSMC Plasticity: Metabolic Reprogramming and Phenotypic Switching.
Cardiovascular drugs and therapy·2026
Introducing Allopurinol to the Medical Treatment of Marfan Syndrome: Advantages, Limitations, and Potential Extension to other Aortopathies.
Cardiovascular drugs and therapy·2026
Apixaban Versus LMWH in CAT/VTE: A Comment on Clinical and Methodological Heterogeneity.
Cardiovascular drugs and therapy·2026
Dendritic Cells in the Immunoregulation of Myocardial Infarction: Mechanisms and Therapeutic Strategies.
Cardiovascular drugs and therapy·2026
Vascular Immunometabolism in Atherosclerosis: Emerging Roles of Glycometabolic Reprogramming in Immune and Vascular Cells.
Cardiovascular drugs and therapy·2026